Immunization News and Research

RSS

Antitumor vaccine

How can we induce the body to use its own weapon, the immune system, to battle cancer" In principle, by the same means used against infectious diseases: immunization.

18 Jun 2007

Genetic factors linked to adverse events related to smallpox vaccination

The study, published in the July 15th issue of The Journal of Infectious Diseases, now available online, may have implications for predicting adverse events from other live vaccines. .

17 Jun 2007

New data on the performance of meningitis vaccine in West African children

The Meningitis Vaccine Project (MVP) today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine,expected to sell initially for 40 US cents a dose,will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.

14 Jun 2007

New vaccine promises end of devastating meningitis epidemics in Africa

Scientists are optimistic that a new meningitis vaccine will end the risk of devastating major epidemics; the new vaccine protects against meningitis A, the deadliest form of the disease.

11 Jun 2007

Preparing for a baby

Planning for pregnancy can help your baby get the best possible start in life. Here are eight valuable tips from Barbara Coulter-Smith, D.O., an obstetrician/gynecologist on the medical staff at Baylor Regional Medical Center at Grapevine.

8 Jun 2007

Research points to a broadly-protective HIV vaccine

New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus.

1 Jun 2007

International studies show high efficacy for Gardasil

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.

1 Jun 2007

Study suggests potential for a broadly-protective HIV vaccine

30 May 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

Researchers successfully treated type 1 diabetic mice with a vaccination

The vaccine they designed in this model included structures that the immune system mistakenly attacks in type 1 diabetes.

28 May 2007

Antibody-based therapies effective at controlling malaria

Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S.

18 May 2007

Lack of association between Rh status, Rh immune globulin in pregnancy and autism

The increase in the number of diagnosed cases of autism in recent years has sparked concern that environmental toxins may cause this complex disorder.

17 May 2007

Environmental toxins may cause autism

The increase in the number of diagnosed cases of autism in recent years has sparked concern that environmental toxins may cause this complex disorder.

17 May 2007

Health workers to get mumps booster in battle against the spread of the disease

The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.

14 May 2007

Assessment of state immunization requirements for healthcare workers and patients

A new study shows wide state-to-state variations in laws regulating vaccinations for health care workers and patients, setting the stage for future research to determine whether more laws could serve as effective tools to combat infectious diseases.

9 May 2007

Researchers develop first antibody that detects gene mutations that cause amyotrophic lateral sclerosis

Researchers at the University of Toronto's Faculty of Medicine have developed the first antibody that detects the only known cause of amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease.

9 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

Some physicians not purchasing, restricting recipients of Gardasil because of cost, Washington Post reports

Inadequate reimbursement from insurance companies for Merck's human papillomavirus vaccine Gardasil is leading some physicians to refuse to purchase the vaccine and restricting the recipients to those whose insurers have agreed to pay a "reasonable" fee, the Washington Post reports (Boodman, Washington Post , 5/1).

2 May 2007

Some doctors refuse to purchase cervical cancer vaccine because of low reimbursements

Some physicians are refusing to purchase Merck's cervical cancer vaccine Gardasil or are restricting who receives it because they say insurance reimbursements for the vaccine are too low, the Washington Post reports.

2 May 2007